A Comprehensive Guide to Healthcare Market Research Companies in Australia

Sep 09, 2025By Joel Ballena

JB

Understanding Healthcare Market Research in Australia

Australia’s healthcare market research industry is experiencing robust growth, with market value projected to reach $382.3 billion by 2033 and analytics segments expanding at a CAGR of 20% from 2025–2033.

Agencies such as Ipsos, IQVIA, and The Insights Loop are instrumental in guiding pharmaceutical, biotech, provider, and policy organisations to navigate complex local dynamics, evolving regulations (PBS/TGA), and consumer behaviour—all through actionable, data-driven insights and advanced behavioural methodologies.

Rating of employment and unemployment or mortality and fertility in Australia, concept. 3D rendering isolated on white background

Understanding Healthcare Market Research in Australia

Healthcare market research identifies gaps, shapes commercial strategies, and drives improvements in care delivery. Australian agencies gather data on treatment patterns, patient journeys, and prescriber attitudes, interpreting this in the context of digital health innovation, widespread telemedicine adoption, and regulatory evolution. In 2025, over 47% of Australians were estimated to have at least one chronic disease, underscoring the vital role of research in segmenting patient populations and identifying growth opportunities for preventive care and wellness programs.

Australia is home to several renowned healthcare market research companies. Some of the top firms include:

Ipsos Australia

Ipsos is recognised globally for comprehensive healthcare market research across public policy, health services, and insurance. In Australia, Ipsos leads large-scale qualitative and quantitative studies, integrating traditional and digital methodologies. A recent Ipsos study helped health agencies refine mental health programs by analysing consumer segmentation and delivering data-driven recommendations for population-wide interventions—demonstrating evidence-based outcomes for real-world healthcare policy.

IQVIA

IQVIA merges cutting-edge analytics, real-world datasets (EMRs, clinical outcomes, prescription tracking), and decade-long expertise to empower clients in market access, regulatory planning, and patient journey mapping across Australia's life sciences landscape. IQVIA’s predictive analytics helped a pharmaceutical client optimise launch planning for a new biologic—using claims and prescribing data to forecast adoption rates and shift promotional spend based on region-specific insights.

The Insights Loop

The Insights Loop is an Australian specialist integrating behavioural science frameworks into every project to reveal both rational and emotional stakeholder drivers. For example, a recent immunisation campaign identified parental hesitancy triggers using the COM-B and Theory of Planned Behaviour models; targeted messaging increased uptake among priority demographics and influenced prescribing behaviour in paediatric clinics. Their capabilities are especially valuable for pharma and medtech companies navigating PBS/TGA compliance and commercial launch strategy.

Key Trends and Technologies Transforming Healthcare Market Research

Global healthcare/Asia

Australian market research now leverages interactive survey platforms, artificial intelligence, and real-time data collection for speed and accuracy. Mixed-methods—combining quantitative surveys with qualitative interviews—allow agencies to blend deep emotional analysis with robust data, enhancing predictive insight generation. Growth in healthcare analytics alone is set to reach USD 692.1 million by 2033, with predictive analytics the fastest-growing segment.

Challenges and Opportunities in the Australian Context

Strict privacy regulations, highly diverse populations, and complex funding systems (PBS/TGA) demand rigorous research approaches. Only agencies employing local expertise, advanced technology, and behavioural frameworks can deliver nuanced, actionable results that address both clinical and commercial priorities. Effectively, agencies help clients spot opportunities for early intervention, optimised market access, and stakeholder engagement—addressing rising chronic disease rates and supporting value-based health models.

How to Choose the Right Healthcare Market Research Agency

Pharmaceutical marketers and healthcare organisations should assess agencies based on:

  • Proven experience in similar therapeutic areas (e.g., neurology, oncology, chronic disease)
  • Capability in advanced analytics, real-world data, and compliance advisory
  • Use of behavioural frameworks to supplement traditional research
  • Adaptability to local regulatory and commercial environments
healthcare challenges

Client Testimonial

💡 “…They are not a traditional market research agency. They act as insights-driven consultants and partner with us to provide tangible interventions to drive behaviour change from HCPs and patients.”
– Market Insights Lead, APAC

Follow us here for weekly insights.